April 10, 2018
Epizyme (NASDAQ:EPZM), a clinical-stage company developing novel epigenetic therapies, announced today its first-in-human data on the effects of EZH2 inhibition...
March 15, 2018
Solid evidence for the use of cannabinoids in epilepsy is cause for optimism about the future of medical cannabis.
February 21, 2018
TG Therapeutics (NASDAQ:TGTX) announced the publication of the results from the Phase 1 first-in-human study of umbralisib (TGR-1202), the Company’s...
February 6, 2018
GW Pharmaceuticals announced the European Medicines Agency accepted its application for Epidiolex, a cannabidiol treatment of seizures.
May 18, 2017
ENDRA Life Sciences renewed its global collaboration agreement with GE Healthcare to develop ENDRA's clinical platform Thermo-Acoustic Enhanced UltraSound.
February 17, 2017
Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and Nasdaq: TIG) (“TiGenix”) today announced new data...
February 13, 2017
Medtronic plc (NYSE: MDT) today announced that its market-leading coronary portfolio will now include the DxTerity Diagnostic Angiography Catheter line...